Skip to main content

The History of DSM

  • Chapter
  • First Online:
Book cover Making the DSM-5

Abstract

Psychiatric diagnosis has proven far more complicated than anyone believed 50 years ago when the first edition of the Diagnostic and Statistical Manual saw the light of day. Psychiatry has always had a nosology, or classification of diseases, beginning with the rough categories established in the early nineteenth century. Between the late nineteenth and mid-twentieth centuries, psychiatric classification was shaped by individual authorities, in particular by the great German nosologist Emil Kraepelin.

The DSM series of the American Psychiatric Association grew out of a desire to create an American system in line with the International Classification of Diseases series issued by the World Health Organization. In some ways its evolution represents progress towards a genuine medical model of classification. Yet in other respects the series has been hijacked by consensus and horse-trading, becoming a political rather than scientific document. Despite enormous investments of time, thought and academic firepower, the process of establishing a reliable nosology of psychiatric illness continues to elude our grasp.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Author not identified in accordance with the ground rules of the listserv.

References

  1. American College of Neuropsychopharmacology. In the beginning.... The origin of the American College of Neuropsychopharmacology. Brentwood, TN: ACNP; 1990.

    Google Scholar 

  2. Pinel P. Traité médico-philosophique sur l’aliénation mentale. 2nd ed. Paris: Brosson; 1809.

    Google Scholar 

  3. Heinroth FCA. Lehrbuch der Störungen des Seelenlebens. Leipzig: Vogel; 1818.

    Google Scholar 

  4. Bell LV. On a form of disease resembling some advanced stages of mania and fever, but so contradistinguished from any ordinarily observed or described combination of symptoms, as to render it probable that it may be an overlooked and hitherto unrecorded malady. Am J Insanity. 1849;6(2):97–127, 99.

    Google Scholar 

  5. Delasiauve L. Du diagnostic différentiel de la lypémanie. Ann Méd Psychol. 1851;(3):380–442, 380.

    Google Scholar 

  6. Kraepelin E. Compendium der Psychiatrie. Leipzig: Abel; 1883.

    Google Scholar 

  7. Kraepelin E. Psychiatrie: ein kurzes Lehrbuch für Studierende und Ärzte. 8th ed. Leipzig: Barth; 1909–1915.

    Google Scholar 

  8. Gaupp R. Die Frage der kombinierten Psychosen. Zeits Neurol Psychiatry. 1926;76(1):73–80, 77–8.

    Google Scholar 

  9. Bleuler E, Jung CG. Komplexe und Krankheitsursachen bei Dementia praecox. Zentralbl Nervenheilk Psychiatr. 1908;19:220–7.

    Google Scholar 

  10. Kraepelin E. Psychiatrie: ein kurzes Lehrbuch für Studierende und Ärzte. 6th ed. Leipzig: Barth; 1899.

    Google Scholar 

  11. Kraepelin E. Die Abgrenzung der Paranoia. Allg Zeits Psychiatr. 1894;50:1080–1.

    Google Scholar 

  12. Lewis A. “Endogenous” and “exogenous”: a useful dichotomy? Psychol Med. 1971;1(3):191–6.

    Article  PubMed  CAS  Google Scholar 

  13. Stengel E. Classification of mental disorders. Bull World Health Organ. 1959;21(4–5):601–63.

    PubMed  CAS  Google Scholar 

  14. Menninger WC. Psychiatric nomenclature. J Nerv Ment Dis. 1946;104(2):180–99.

    Article  Google Scholar 

  15. Fink M. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 9. Brentwood, TN: ACNP; 2011. p. 76.

    Google Scholar 

  16. World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death. 6th revision [later known as ICD-6] 2 volumes. Geneva: WHO; 1948–49.

    Google Scholar 

  17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: APA; 1952.

    Google Scholar 

  18. Klein DF, Fink M. Psychiatric reaction patterns to imipramine. Am J Psychiatry. 1962; 119(5):432–8.

    PubMed  CAS  Google Scholar 

  19. Müller C. Lexikon der Psychiatrie. Berlin: Springer; 1973. p. 409–15.

    Book  Google Scholar 

  20. Lambert P. Discussion. In: Bradley PB, Deniker P, Raduoco-Thomas C, editors. Neuro-­psychopharmacology: proceedings of the first international congress of neuro-­psychopharmacology, Rome, September 1958. Amsterdam: Elsevier; 1959. p. 212.

    Google Scholar 

  21. American Psychiatric Association. DSM-II: diagnostic and statistical manual of mental disorders. 2nd ed. Washington, DC: APA; 1968.

    Google Scholar 

  22. Kendell RE, Cooper JE, Gourlay AJ, Copeland JRM, Sharpe L, Gurland BJ. Diagnostic criteria of American and British psychiatrists. Arch Gen Psychiatry. 1971;25(2):123–30.

    Article  PubMed  CAS  Google Scholar 

  23. Frank J. Discussion comment. In: Zubin J, Freyhan F, editors. Disorders of mood. Baltimore: Johns Hopkins Press; 1972. p. 30.

    Google Scholar 

  24. Katz M, Williams TA, Shield JA. Recent advances in the psychobiology of the depressive illnesses. Proceedings of a workshop hosted by the College of William and Mary in Virginia, April 30 through May 2, 1969. National Institute of Mental Health, Division of Extramural Research Programs, Clinical Research branch. Washington, DC: Superintendent of Documents, US Government Printing Office; 1972.

    Google Scholar 

  25. Weissman M. Interview. Gerald Klerman and psychopharmacology. In: Healy D, editor. The psychopharmacologists, vol. 2. London: Altman; 1998. p. 521–42, 530.

    Google Scholar 

  26. Clayton PJ. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 7. Brentwood, TN: ACNP; 2011. p. 99.

    Google Scholar 

  27. Henn FA. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 8. Brentwood, TN: ACNP; 2011. p. 154.

    Google Scholar 

  28. Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Muñoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26(1):57–63.

    Article  PubMed  CAS  Google Scholar 

  29. Katz MM. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 9. Brentwood, TN: ACNP; 2011. p. 200.

    Google Scholar 

  30. Shorter E. Bipolar disorder in historical perspective. In: Parker G, editor. Bipolar II disorder: modeling, measuring and managing. 2nd ed. Cambridge, UK: Cambridge University Press; 2012. p. 1–9.

    Chapter  Google Scholar 

  31. Spitzer RL, Endicott J, Robins E, Kuriansky J, Gurland B. Preliminary report of the reliability of research diagnostic criteria applied to psychiatric case records. In: Sudilovsky A, Gershon S, Beer B, editors. Predictability in psychopharmacology: preclinical and clinical correlations. New York: Raven; 1975. p. 1–47.

    Google Scholar 

  32. Shorter E. How everyone became depressed: the rise and fall of the nervous breakdown. New York: Oxford University Press; 2013.

    Google Scholar 

  33. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Arch Gen Psychiatry. 1978;35(6):773–82.

    Article  PubMed  CAS  Google Scholar 

  34. Klein DF. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 9. Brentwood, TN: ACNP; 2011. p. 214.

    Google Scholar 

  35. Klerman GL, Endicott J, Spitzer R, Hirschfeld RMA. Neurotic depressions: a systematic analysis of multiple criteria and meanings. Am J Psychiatry. 1979;136(1):57–61.

    PubMed  CAS  Google Scholar 

  36. Rudorfer MV, Clayton PJ. Depression, dementia and dexamethasone suppression [letter]. Am J Psychiatry. 1981;138(5):701.

    PubMed  CAS  Google Scholar 

  37. Healy D, editor. The psychopharmacologists, vol. 2. London: Altman; 1998. p. 555.

    Google Scholar 

  38. Taylor MA, Vaidya NA. Descriptive psychopathology: the signs and symptoms of behavioral disorders. Cambridge, UK: Cambridge University Press; 2009.

    Google Scholar 

  39. McHugh PR, Slavney PR. Mental illness—comprehensive evaluation or checklist? N Engl J Med. 2012;366(20):1853–5, 1854.

    Google Scholar 

  40. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (third edition—revised): DSM-III-R. Washington, DC: APA; 1987.

    Google Scholar 

  41. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.

    Article  PubMed  CAS  Google Scholar 

  42. Frances A. Opening Pandora’s box: the 19 worst suggestions for DSM-5. Psychiatric Times, 11 Feb 2010.

    Google Scholar 

  43. Frances A, Cooper AM. Descriptive and dynamic psychiatry: a perspective on DSM-III. Am J Psychiatry. 1981;138(9):1198–202.

    PubMed  CAS  Google Scholar 

  44. Frances A. Dr Frances responds to Dr Carpenter: a sharp difference of opinion. Psychiatric Times, 9 Jul 2009.

    Google Scholar 

  45. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160(1):4–12, 5, 11.

    Google Scholar 

  46. Clayton PJ, Guze SB, Cloninger CR, Martin RL. Unipolar depression: diagnostic inconsistency and its implications. J Affect Disord. 1992;26(2):111–6.

    Article  PubMed  CAS  Google Scholar 

  47. Taylor MA, Fink M. Melancholia: the diagnosis, pathophysiology, and treatment of depressive illness. Cambridge, UK: Cambridge University Press; 2006.

    Book  Google Scholar 

  48. Fink M, Taylor MA. Catatonia: a clinician’s guide to diagnosis and treatment. Cambridge, UK: Cambridge University Press; 2003.

    Book  Google Scholar 

  49. Craddock N, Owen MJ. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry. 2007;6(2):84–91.

    PubMed  Google Scholar 

  50. Carroll B. Comment on: as precisely as possible. In: 1 Boring old man [Internet]. http://1boringoldman.com/index.php/2011/12/05/as-precisely-as-possible/. Accessed 5 Dec 2011.

  51. Parker G, Hadzi-Pavlovic D, Wilhelm K, Hickie I, Brodaty H, Boyce P, et al. Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry. 1994;164(3):316–26.

    Article  PubMed  CAS  Google Scholar 

  52. Lewis AJ. Melancholia: a clinical survey of depressive states. J Ment Sci. 1934;80(329):277–378, 280.

    Google Scholar 

  53. Spitzer R. Interview. In: Healy D, editor. The psychopharmacologists, vol. 3. London: Altman; 1998. p. 427.

    Google Scholar 

Download references

Acknowledgments

For comments on an earlier version, I am grateful to Bernard Carroll and Max Fink.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward Shorter .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Shorter, E. (2013). The History of DSM. In: Paris, J., Phillips, J. (eds) Making the DSM-5. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6504-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6504-1_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6503-4

  • Online ISBN: 978-1-4614-6504-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics